IMAAVY
RegisteredWord Mark
•
Ownership
J&
Owner Name
Type: Organization / Corporation
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
Critical Dates
First Use Date
May 7, 2025
Filing Date
Jul 17, 2023
Registration Date
Oct 28, 2025
Mark Descriptions
Goods
Class 5
Human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases and central nervous system diseases
Mark Elements
Text Mark
IMAAVY
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 04:57 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
The standard character mark IMAAVY covers human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases and central nervous system diseases in International Class 005, along with goods and services in Domestic Classes 006, 018, 044, 046, 051, and 052. It is registered on the Principal Register (Registration No. 8005664) as of October 28, 2025, with first use in commerce on May 7, 2025. Johnson & Johnson, a New Jersey corporation located in New Brunswick, New Jersey, is the owner.
Recent Activity
Filed on July 17, 2023, the mark faced suspension inquiries in 2023 and 2024 before approval and publication for opposition on October 22, 2024. A statement of use was filed and accepted in May through October 2025, leading to registration on October 28, 2025.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach